Open on a desktop browser to explore the interactive map. The knowledge graph needs a larger screen and a pointer. On this device you are limited to the text below.
Dr. Ronald Roth Acu-Cell AI

Dr. Ronald Roth's Nutritional and Metabolic Perspective

Overview of EAAT2 in ALS

  • Critical Function: The EAAT2 (Excitatory Amino Acid Transporter 2) is the primary transporter responsible for removing excess glutamate from the synaptic cleft in the central nervous system.
  • Pathological Loss: In Amyotrophic Lateral Sclerosis (ALS), there is a significant, well-documented loss or dysfunction of EAAT2 in the motor cortex and spinal cord astrocytes.

Metabolic and Nutritional Implications

  • Glutamate Excitotoxicity: The primary consequence of EAAT2 loss is the accumulation of extracellular glutamate, leading to chronic overactivation of receptors, excessive calcium influx, and neurotoxic cell death (excitotoxicity).
  • Underlying Biochemical Stressors: While conventional medicine often views this as a primary neurodegenerative cascade, from a metabolic standpoint, we must look at what triggers or worsens astrocyte dysfunction. Key factors include:
  • Oxidative Stress and Free Radicals: High levels of oxidative damage impair protein synthesis and membrane transport functions in glial cells.
  • Mitochondrial Dysfunction: Astrocytes require immense energy (ATP) to clear neurotransmitters; failing energy production halts transporter efficiency.
  • Mineral Imbalances and Toxins: Heavy metal toxicity (such as mercury or lead) and specific nutritional deficiencies can exacerbate neurological inflammation and oxidative injury.

Supportive Nutritional Approach

  • Antioxidant Protection: Utilizing targeted antioxidants to combat the oxidative stress that damages glial membranes.
  • Mitochondrial Support: Supporting cellular energy pathways to ensure astrocytes have the functional capacity to maintain neurotransmitter homeostasis.
  • Reducing Excitotoxic Stress: Addressing dietary triggers and supporting overall metabolic equilibrium to minimize the burden on compromised neural pathways.
AI-generated in the approach of Dr. Ronald Roth. Not his own words.
Traversing graph…
Connections

Glutamate - connections

Glutamate ->

ALS symptoms - connections

-> ALS symptoms

  • Selenium, Sulfur - Affects (Condition: lowered level; Outcome: improvement; Degree: pronounced; Duration: short-term; Basis: trial)
  • Minocycline - Delays (Aspect: onset; Model: mouse)
  • Minocycline - Slows (Aspect: progression; Model: mouse)
  • Minocycline, Tamoxifen - Stabilizes (Evidence: reported)

Amyotrophic lateral sclerosis - connections

Amyotrophic lateral sclerosis ->

-> Amyotrophic lateral sclerosis

  • Dietary sulfur, Supplemental sulfur - Adjusted For (Recommendation: should; Manner: accordingly)
  • Selenium - Associated With (Level: above normal; Location: intracellular)
  • Sulfur - Associated With (Level: elevated; Location: intracellular)
  • Lithium - Benefits (Evidence: animal models; Certainty: reported)
  • Eggs, Garlic, Onions - Causes (Polarity: negative)
  • Diet - Causes (Polarity: not)
  • Mercury poisoning - Causes (Scope: rare_forms; Certainty: attributable)
  • Mercury poisoning - Causes (Scope: some forms; Frequency: rare)
  • Minocycline - May Treat (Modality: may; Basis: findings; Novelty: new)
  • Neurontin - Prescribed For (Frequency: sometimes)
  • Lithium - Stops (Aspect: progression; Evidence: clinical trials; Recency: recent; Certainty: suggested; Modality: may)
  • Rilutek - Treats
  • Lithium - Treats (Evidence: reported; Model: animal; Benefit: beneficial)
Overview
Loading graph...
Display TOP 100%
Loading full knowledge graph…
Building graph…
Preparing…
Filter by Relationship
Filter by Type
Some information may be incomplete, disputed, or incorrect. Review the supporting sources.